Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma
Status:
Recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
The goal of this phase 2 trial is to test the safety and efficacy of azacitidine when given
together with PD-1 therapy in treating patients with relapsed/refractory classic Hodgkin
lymphoma.